Topics:

Atrial Fibrillation

Bisphosphonates Increase Risk of Incident AF

The good news? Bisphosphonates are highly effective treatment for osteoporosis, osteopenia, and the prevention of fractures. The bad? Bisphosphonates have been linked to the development of atrial fibrillation.

 

Atrial Fibrillation

CHA2DS2-VASc scoring system

What is your command of the components of this risk prediction tool for patients with atrial fibrillation? Find out with our 4-question quiz.

Rhythm control in atrial fibrillation

When is a rhythm control strategy appropriate? Which patients are candidates for amiodarone? When is AF ablation the answer? Here, a top-line review of rhythm control for atrial fibrillation.

Edoxaban, NOAC antidote

The absence of an antidote may soon disappear as a reason to avoid prescribing a novel oral anticoagulant to patients with atrial fibrillation, based on promising phase III trial results.

The risk for major bleeding and GI hemorrhage in patients taking dabigatran was greater than in those taking warfarin; warfarin, however, was associated with a greater risk of intracranial hemorrhage.

In analysis of this randomized controlled trial of apixaban vs warfarin for nonvalvular atrial fibrillation, there was an increased risk of stroke and systemic embolism among patients taking amiodarone and warfarin.

New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.

A nurse describes his own bout with atrial fibrillation—the symptoms and his attempts to cardiovert to normal rhythm—from his hospital bed.

Pages

Subscribe to Atrial Fibrillation on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.